65 -- PHARMACEUTICALS

The Department of the Navy, Bureau of Medicine and Surgery, through the National Naval Medical Center Acquisition Management Service, intends to award a sole source contract to Anazao Health for the supply of specific pharmaceutical products primarily related to iodine and Iodine-131 MIBG doses used in therapy and dosimetry. The contract calls for the purchase of 70 units of 3 millicuries iodine, 12 units of 10 millicuries iodine, and 7000 units of a 123 MIBG dose for Iodine-131 therapy. This procurement is conducted under the NAICS code 446110 and follows the authority of the Clinger Cohen Act of 1996, specifically FAR Part 6.302-1, citing only one responsible source and no acceptable alternatives capable of meeting the agency’s requirements. The solicitation is a combined synopsis/solicitation/notice of intent, with no additional notices to be issued, and questions regarding the solicitation are directed to the Senior Purchasing Agent, Bianca S Roman. The announcement represents a request for competitive quotes with a closing date of 2:00 P.M. EST on March 6, 2008. The contracting office is located at the Walter Reed National Military Medical Center in Bethesda, Maryland, acting under the Department of Defense. The process emphasizes the exclusivity of supplier selection based on the specialized nature of the supplies, and potential offerors must submit inquiries via the provided contact details. The contract title is "65 -- PHARMACEUTICALS," and the procurement is aimed at fulfilling urgent medical supply needs within the Navy’s medical operational framework.